A federal bankruptcy judge said on Friday he will approve a restructuring plan for drugmaker Purdue Pharma that includes a $7.4 billion settlement resolving claims that it fueled the U.S. opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback